Use of immidazoquinolinamines as adjuvants in DNA vaccination

Details for Australian Patent Application No. 2001287908 (hide)

Owner Glaxo Group Limited

Inventors Topley, Peter; Tite, John Philip; Thomsen, Lindy Louise

Agent Davies Collison Cave

Pub. Number AU-B-2001287908

PCT Pub. Number WO02/24225

Priority 0023008 20.09.00 GB

Filing date 20 September 2001

Wipo publication date 2 April 2002

Acceptance publication date 30 June 2005

International Classifications

A61K 039/39 Medicinal preparations containing antigens or antibodies - characterised by the immunostimulating additives, e.g. chemical adjuvants

C07D 215/42 Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems

C07D 215/22 Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems

A61P 031/00 Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

A61K 048/00 Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases

Event Publications

30 June 2005 Application Accepted

  Published as AU-B-2001287908

27 October 2005 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2001287909

2001287907